The seed capital will help UAB-founded TriAltus Bioscience commercialise its protein purification materials, which are already being used by research clients in the US, Brazil and EU.
TriAltus Bioscience, a US-based protein purification technology spinout of University of Alabama at Birmingham (UAB), has raised $1.6m in a seed round featuring unnamed angel investors.
Founded in 2017, TriAltus Bioscience is commercialising protein purification materials that utilise a technique called CL-4 affinity purification to quickly isolate proteins at a higher purity than alternative methods.
The technology is designed for scientific research applications such as the production of therapeutic proteins. In addition to the purification technology, TriAltus also…
